|
Adverse Event
|
RRa
|
99.7% CI
|
P-valueb
|
|---|
|
Any Complications
|
0.97
|
0.92–1.03
|
0.138
|
|
Urinary tract infection
|
1.09
|
0.96–1.23
|
0.040
|
|
Blood transfusion
|
1.02
|
0.96–1.07
|
0.408
|
|
Extended length of stay (> 3 days)
|
0.94
|
0.91–0.97
|
< 0.001
|
|
Readmission
|
0.91
|
0.86–0.97
|
< 0.001
|
|
Death
|
1.00
|
0.72–1.39
|
0.973
|
|
Pneumonia
|
0.88
|
0.73–1.07
|
0.059
|
|
Return to the operating room
|
0.91
|
0.82–1.01
|
0.007
|
|
Wound complications
|
0.98
|
0.88–1.09
|
0.586
|
|
Thromboembolic complicationsc
|
0.99
|
0.90–1.09
|
0.825
|
|
Sepsis/septic shock
|
0.92
|
0.74–1.16
|
0.303
|
|
Respiratory complications
|
0.91
|
0.68–1.21
|
0.322
|
|
Cardiac complications
|
1.00
|
0.81–1.23
|
0.993
|
|
Renal complications
|
0.83
|
0.63–1.10
|
0.047
|
|
Stroke/cerebrovascular accident
|
1.03
|
0.70–1.51
|
0.805
|
- aPoisson regressions with robust error variance were used to compare these variables. Adjusted for age, gender, BMI, ASA class, diabetes, and smoking status
- bBold fonts indicate statistical significance (significant at P < 0.003 due to Bonferroni correction for multiple comparisons). RR Relative risk, CI Confidence interval (99.70% CI due to Bonferroni)
- cIncludes deep vein thrombosis and pulmonary embolism
